BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Jan 03, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Stimuvax: Phase III ongoing

An independent DMC recommended continuation of the Phase III START trial evaluating Stimuvax. In 2010, Merck KGaA restarted the trial after FDA partially lifted a clinical hold on the liposomal vaccine. The agency placed the hold...

Read the full 156 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >